TABLE 4.
Demographic information of the subjects for validation.
Group | ID | Age | Clinical diagnosis | Neuropathological diagnosis | PMI (h) |
Middle-aged female | 1 | 56 | Squamous cell carcinoma | No diagnostic abnormality | 24 |
2 | 57 | Cardiomyopathy | Ischemic infarcts | 24 | |
3 | 53 | Severe Anemia | No diagnostic abnormality | 25 | |
4 | 57 | Squamous cell carcinoma | Cerebrovascular disease | 24 | |
5 | 59 | Acute myeloid leukemia | Cerebrovascular disease | 31 | |
Middle-aged male | 6 | 56 | Diabetes | Ischemic encephalopathy | 24 |
7 | 50 | Coronary artery disease | Cerebrovascular disease | 26 | |
8 | 59 | Myeloproliferative neoplasms | No diagnostic abnormality | 19 | |
9 | 50 | Acute necrotizing pancreatitis | Cerebrovascular disease | 23 | |
10 | 52 | Diabetic ketoacidosis | Cerebrovascular disease | 20 | |
11 | 42 | End-stage renal disease | Cerebrovascular disease | 58 | |
Aged female | 12 | 74 | Adenocarcinoma | Arteriosclerosis | 24 |
13 | 86 | Cardiac arrest | Primary age-related tauopathy | 29 | |
14 | 82 | Myocardial infarction | Primary age-related tauopathy | 22 | |
15 | 77 | Diabetes | Primary age-related tauopathy | 14 | |
16 | 88 | Metastatic adenocarcinoma | No diagnostic abnormality | 7 | |
Aged male | 17 | 83 | Adenocarcinoma | Arteriosclerosis | 89 |
18 | 80 | Fibromuscular stroma | Cerebrovascular disease | 16 | |
19 | 82 | Cholecystitis | No diagnostic abnormality | 11 | |
20 | 97 | Multiple organ failure | Cerebrovascular disease | 53 | |
21 | 89 | Pancreatic cancer | Cerebrovascular disease | 22 |